A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture
Clinical trial NCT05352516 · COMPLETED
Trial details
- NCT number
- NCT05352516
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2023-12-17
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.